id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-1978-N-0018-0135,FDA,FDA-1978-N-0018,Letter from FDA CDER to Arlington Dermatology Clinic South,Other,Letter(s),1994-10-17T04:00:00Z,1994,10,,,2019-07-22T16:53:28Z,,0,0,090000648055a1d7
FDA-1978-N-0018-0133,FDA,FDA-1978-N-0018,"Letter from FDA CDER to Person & Covey, Inc.",Other,Letter(s),1994-09-15T04:00:00Z,1994,9,,,2019-07-22T15:37:29Z,,0,0,090000648055a1c0
FDA-1978-N-0018-0132,FDA,FDA-1978-N-0018,"Memorandum of Telephone Conversation between Arent, Fox, Kintner, Plotkin & Kahn and FDA/CDER, August 22, 1994",Other,Memorandum,1994-09-06T04:00:00Z,1994,9,,,2019-08-02T14:52:14Z,,0,0,090000648055a19c
FDA-1978-N-0018-0130,FDA,FDA-1978-N-0018,"Internal Memorandum from Director Monograph Review Staff (HFD-810) to Dockets Management Branch (HFA-305) August 3, 1994 re: Comment from Canadian Dermatology Association",Supporting & Related Material,Comment(s),1994-08-08T04:00:00Z,1994,8,,,2019-08-02T16:35:11Z,,0,0,090000648055a16d
FDA-1978-N-0018-0129,FDA,FDA-1978-N-0018,"Correction to Memorandum of Meeting between FDA/CDER, et al., and Givauden-Roure Corporation, et al., May 11, 1994 from FDA/CDER",Other,Correction(s),1994-07-28T04:00:00Z,1994,7,,,2019-07-23T15:57:14Z,,0,0,090000648055a12c
FDA-1978-N-0018-0459,FDA,FDA-1978-N-0018,"Acknowledgment Letter from FDA/DDM to Arent Fox Kintner Plotkin & Kahn on behalf of Estee Lauder, Inc.",Other,Acknowledgement Letter/Receipt,1994-07-28T04:00:00Z,1994,7,,,2019-07-23T15:01:45Z,,0,0,090000648055a8b8
FDA-1978-N-0018-0128,FDA,FDA-1978-N-0018,Letter from FDA/CDER to Ivy Laboratories,Other,Letter(s),1994-07-27T04:00:00Z,1994,7,,,2019-07-22T18:55:33Z,,0,0,090000648055a126
FDA-1978-N-0018-0127,FDA,FDA-1978-N-0018,Letter from FDA/CDER to Temple University Medical Practices,Other,Letter(s),1994-07-19T04:00:00Z,1994,7,,,2019-07-22T18:26:46Z,,0,0,090000648055a11b
FDA-1978-N-0018-0125,FDA,FDA-1978-N-0018,"Memorandum of Meeting between FDA/CDER, et al., and Givauden-Roure Corporation, et al., May 11, 1994",Other,Memorandum,1994-07-07T04:00:00Z,1994,7,,,2019-07-22T17:58:20Z,,0,0,090000648055a116
FDA-1978-N-0018-0124,FDA,FDA-1978-N-0018,Letter from FDA CDER to King & Spaulding,Other,Letter(s),1994-06-30T04:00:00Z,1994,6,,,2019-07-29T18:43:55Z,,0,0,090000648055a10e
FDA-1978-N-0018-0123,FDA,FDA-1978-N-0018,"Memorandum of Meeting between FDA/CDER, Dr. Madhu Pathak, et al., and Givaudan-Roure Corporation, et al., May 12, 1994",Other,Memorandum,1994-06-30T04:00:00Z,1994,6,,,2019-09-04T17:19:22Z,,0,0,090000648055a10b
FDA-1978-N-0018-0122,FDA,FDA-1978-N-0018,Sunscreen Drug Products for Over-The-Counter Human Use; Proposed Amendment to the Tentative Final Monograph; Reopening of Comment Period,Notice,Notice of Extension,1994-06-14T04:00:00Z,1994,6,1994-06-14T04:00:00Z,1994-08-23T03:59:59Z,2019-07-19T19:49:02Z,94-13933,0,0,090000648055a108
FDA-1978-N-0018-0120,FDA,FDA-1978-N-0018,Letter from FDA/CDER to King & Spalding,Other,Letter(s),1994-05-12T04:00:00Z,1994,5,,,2019-07-22T18:47:28Z,,0,0,090000648055a020
FDA-1978-N-0018-0117,FDA,FDA-1978-N-0018,Answer Letter from FDA/CDER to Dr. Beverly Summers,Other,Letter(s),1994-04-06T04:00:00Z,1994,4,,,2019-07-22T12:23:19Z,,0,0,0900006480559fad
FDA-1978-N-0018-0119,FDA,FDA-1978-N-0018,Answer Letter from FDA/CDER to Nicholas J. Lowe,Other,Letter(s),1994-04-06T04:00:00Z,1994,4,,,2019-07-22T12:32:57Z,,0,0,0900006480559fd3
FDA-1978-N-0018-0118,FDA,FDA-1978-N-0018,Answer Letter from FDA/CDER to James L. Boren,Other,Letter(s),1994-04-06T04:00:00Z,1994,4,,,2019-07-22T12:28:04Z,,0,0,0900006480559fb4
FDA-1978-N-0018-0116,FDA,FDA-1978-N-0018,"Letter from FDA/CDER to Morgan, Lewis & Bockius",Other,Letter(s),1994-02-28T05:00:00Z,1994,2,,,2019-07-26T11:46:52Z,,0,0,0900006480559ec3
FDA-1978-N-0018-0465,FDA,FDA-1978-N-0018,Answer Letter from FDA/Associate Commissioner for Legislative Affairs to Comment from the Honorable Congressman Bob Clement,Other,Answer,1994-02-24T05:00:00Z,1994,2,,,2019-07-19T11:59:16Z,,0,0,090000648055a8c9
FDA-1978-N-0018-0466,FDA,FDA-1978-N-0018,Answer Letter from FDA/Associate Commissioner for Legislative Affairs to Comment from the Honorable Senator Harlan Mathews,Other,Answer,1994-02-24T05:00:00Z,1994,2,,,2019-07-19T12:09:07Z,,0,0,090000648055a8cd
FDA-1978-N-0018-0111,FDA,FDA-1978-N-0018,Letter from FDA/CDER to The Proctor & Gamble Company,Other,Letter(s),1994-02-17T05:00:00Z,1994,2,,,2019-07-26T11:53:00Z,,0,0,0900006480559e6e
FDA-1978-N-0018-0108,FDA,FDA-1978-N-0018,Letter from FDA/CDER to The Proctor & Gamble Company,Other,Letter(s),1994-01-26T05:00:00Z,1994,1,,,2019-08-05T12:27:33Z,,0,0,0900006480559e05
FDA-1978-N-0018-0109,FDA,FDA-1978-N-0018,Letter from FDA/CDER to Nonprescription Drug Manufacturers Association,Other,Letter(s),1994-01-26T05:00:00Z,1994,1,,,2019-08-05T12:25:05Z,,0,0,0900006480559e09
FDA-1978-N-0018-0110,FDA,FDA-1978-N-0018,"Letter from FDA/CDER to The Cosmetic, Toiletry & Fragrance Association",Other,Letter(s),1994-01-26T05:00:00Z,1994,1,,,2019-08-05T12:21:30Z,,0,0,0900006480559e0c
FDA-1978-N-0018-0107,FDA,FDA-1978-N-0018,Letter from SunSmart Inc. to FDA/CDER,Other,Letter(s),1994-01-10T05:00:00Z,1994,1,,,2019-08-05T12:48:55Z,,0,0,0900006480559dfc
FDA-1978-N-0018-0106,FDA,FDA-1978-N-0018,"Memorandum of Meeting between FDA/CDER and Cosmetic, Toiletry, and Fragrance Association October 21 1993",Other,Memorandum,1994-01-10T05:00:00Z,1994,1,,,2019-08-05T12:57:30Z,,0,0,0900006480559df7